Abstract

The term “big data” refers broadly to large volumes of data, often gathered from several sources, that are then analyzed, for example, for predictive analytics. Combining and mining genetic data from varied sources including clinical genetic testing, for example, electronic health records, what might be termed as “recreational” genetic testing such as ancestry testing, as well as research studies, provide one type of “big data.” Challenges and cautions in analyzing big data include recognizing the lack of systematic collection of the source data, the variety of assay technologies used, the potential variation in classification and interpretation of genetic variants. While advanced technologies such as microarrays and, more recently, next-generation sequencing, that enable testing an individual's DNA for thousands of genes and variants simultaneously are briefly discussed, attention is focused more closely on challenges to analysis of the massive data generated by these genomic technologies. The main theme of this review is to evaluate challenges associated with big data in general and specifically to bring the sophisticated technology of genetic/genomic testing down to the individual level, keeping in mind the human aspect of the data source and considering where the impact of the data will be translated and applied. Considerations in this “humanizing” process include providing adequate counseling and consent for genetic testing in all settings, as well as understanding the strengths and limitations of assays and their interpretation.

Highlights

  • Precision medicine in cancer treatment is defined by the National Cancer Institute as a “genetic understanding” of cancer, offering a specific treatment tailored to an individual [1]

  • The main theme of this review is to evaluate challenges associated with big data in general and to bring the sophisticated technology of genetic/genomic testing down to the individual level, keeping in mind the human aspect of the data source and considering where the impact of the data will be translated and applied

  • The application of technologies to generate and interpret big data related to genetic testing holds promise for the future of cancer medicine

Read more

Summary

Frontiers in Oncology

The main theme of this review is to evaluate challenges associated with big data in general and to bring the sophisticated technology of genetic/genomic testing down to the individual level, keeping in mind the human aspect of the data source and considering where the impact of the data will be translated and applied. Considerations in this “humanizing” process include providing adequate counseling and consent for genetic testing in all settings, as well as understanding the strengths and limitations of assays and their interpretation

INTRODUCTION
Laboratory Testing of Germline DNA Variants
Ethical Challenges
Security Challenges
Challenges to Data Sharing
SUMMARY
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call